Technology | Stents Peripheral

Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System from the U.S. Food & Drug Administration (FDA). The device is approved for the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and/or proximal popliteal artery.

Home October 05, 2018
Home
News | Vascular Closure Devices

Teleflex Inc. announced the acquisition of Essential Medical Inc. Based in Exton, Pa., Essential Medical is a privately-held medical device company that has developed and commercialized the CE Marked Manta Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing devices or sheaths ranging in size from 10F to 18F (with maximum outer diameters up to 25F).

Home October 05, 2018
Home
News | Heart Failure

The Ohio State University Wexner Medical Center is first in the country to test a new medical device designed to help patients with advanced heart failure. Cardiologists here performed the first two implants and the patients went home the next day.

Home October 04, 2018
Home
News | FFR Technologies

October 4, 2018 — The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks ...

Home October 04, 2018
Home
Technology | Ultrasound Imaging

Fujifilm SonoSite Inc. announced its entry into the medical informatics space with the launch of a robust point-of-care workflow solution, SonoSite Synchronicity. The software is designed specifically for point-of-care ultrasound to streamline and standardize clinical workflow while delivering administrative efficiencies with flexible credentialing tools.

Home October 04, 2018
Home
News | Hypertension

October 4, 2018 — Pulmonary artery denervation (PADN) is associated with significant improvements in hemodynamic and ...

Home October 04, 2018
Home
Technology | Medical 3-D Printing

Three-dimensional printing company Biomodex, which develops organ twins for advanced physician training, is expanding into the interventional cardiology space with the launch of the Left Atrial Appendage Closure Solution (LAACS). Unveiled at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, the LAACS allows physicians to train on an ultra-realistic, multi-material, 3-D-printed heart.

Home October 04, 2018
Home
News | Stents

October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials ...

Home October 04, 2018
Home
Videos | TCT

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the expo ...

Home October 03, 2018
Home
News | Radiation Dose Management

Image Diagnostics has entered into a product development agreement with ECLS Inc. to design a new radiation shield expected to debut at the 2018 Radiological Society of North America (RSNA) 2018 annual meeting, Nov. 26-30 in Chicago. The radiation shield, conceptualized by ECLS founder James Goldstein, M.D., cardiologist at Royal Oak Michigan’s Beaumont Hospital, is expected to address the adverse health effects of radiation exposure and the strain of long-term wear of protective lead during interventional surgery.

Home October 03, 2018
Home
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon Stertzer, M.D. In this article he shares his views on the current direction and next steps in cardiovascular biomedical technology
Feature

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon ...

Home October 03, 2018
Home
News | Heart Valve Technology

A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and moderate cases of prosthesis-patient mismatch (PPM), meaning the implanted heart valve is too small for the patient, which can lead to inadequate blood flow. The research team from Penn Medicine also found that the risk of death and of heart failure readmissions were 19 percent and 12 percent higher, respectively, after one year as compared to patients without severe PPM.

Home October 03, 2018
Home
News | Hypertension

Two-year results of the Moderato I Study demonstrated immediate, substantial and sustained reduction in blood pressure when BackBeat cardiac neuromodulation therapy (CNT) was used in patients with persistent hypertension (office BP > 150 mmHg). Patients in the study had persistent hypertension despite two or more anti-hypertensive medications and an indication for a pacemaker.

Home October 02, 2018
Home
News | Intra-Vascular Ultrasound (IVUS)

Intravascular ultrasound (IVUS) guidance improved clinical outcomes over angiography guidance during drug-eluting stent (DES) implantation by lowering the rate of target vessel failure at one year in the ULTIMATE trial.

Home October 02, 2018
Home
News | Ultrasound Imaging

October 2, 2018 — GE Healthcare announced an equity investment in SonoSim, which specializes in ultrasound education and ...

Home October 02, 2018
Home
Subscribe Now